Proteobridge

CRO offering drug development and research services for protein array manufacturing

placeKoto City, Tokyo, Japan calendar_todayFounded 2018 groups12 employees language proteo-bridge.co.jp

Innovation

1 patent family — focus: Physics & computing; filing pace active. Cited 3 times.

YearFilings
20241

Investor mix

3 investors on record.

Investor typeCountShare
Private equity133%
Bank & private debt133%
Other / undisclosed133%
Coming soon